Cargando…

Mutational analysis of KRAS and its clinical implications in cervical cancer patients

OBJECTIVE: The predictive and prognostic role of KRAS mutations in cervical cancer remains inconclusive. The aim of this study was to explore the clinicopathological and prognostic relevance of KRAS mutations in invasive cervical cancers (ICC). METHODS: Reverse transcription polymerase chain reactio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Wei, Xiang, Libing, Pei, Xuan, He, Tiancong, Shen, Xuxia, Wu, Xiaohua, Yang, Huijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709530/ https://www.ncbi.nlm.nih.gov/pubmed/29185262 http://dx.doi.org/10.3802/jgo.2018.29.e4

Ejemplares similares

Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers
por: Xiang, Libing, et al.
Publicado: (2014)

PIK3CA mutation analysis in Chinese patients with surgically resected cervical cancer
por: Xiang, Libing, et al.
Publicado: (2015)

Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer
por: Xiang, Libing, et al.
Publicado: (2016)

The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer
por: Jiang, Wei, et al.
Publicado: (2018)

Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1)
por: Jiang, Wei, et al.
Publicado: (2018)

Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma
por: Ye, Shuang, et al.
Publicado: (2017)

Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients
por: Wu, Yutuan, et al.
Publicado: (2020)

The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study
por: Ye, Shuang, et al.
Publicado: (2020)

(18)F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications
por: Ye, Shuang, et al.
Publicado: (2019)

Untangling the KRAS mutated lung cancer subsets and its therapeutic implications
por: Ritu, Kulshrestha, et al.
Publicado: (2021)

Conization Using an Electrosurgical Knife for Cervical Intraepithelial Neoplasia and Microinvasive Carcinoma
por: Xiang, Libing, et al.
Publicado: (2015)

Implications of KRAS mutations in acquired resistance to treatment in NSCLC
por: Del Re, Marzia, et al.
Publicado: (2017)

Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
por: Gökmen, İvo, et al.
Publicado: (2023)

The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations
por: Zheng, Difan, et al.
Publicado: (2016)

Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations
por: Chen, Chih-Chieh, et al.
Publicado: (2013)

Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases
por: Ye, Shuang, et al.
Publicado: (2020)

KRAS mutation in lung metastases from colorectal cancer: prognostic implications
por: Ghidini, Michele, et al.
Publicado: (2015)

The relationships of OSBPL3 expression with KI-67 expression and KRAS mutations in CRC: implications for diagnosis and prognosis
por: Zhang, Min, et al.
Publicado: (2022)

Intratumor heterogeneity and tissue distribution of KRAS mutation in non-small cell lung cancer: implications for detection of mutated KRAS oncogene in exhaled breath condensate
por: Kordiak, Jacek, et al.
Publicado: (2018)

Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands
por: Noordhof, Anneloes L., et al.
Publicado: (2023)

Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

KRAS mutation analysis in ductal carcinoma of the pancreas; prognostic implications in elderly patients
por: Oldani, Alberto, et al.
Publicado: (2013)

Crucial Role of Oncogenic KRAS Mutations in Apoptosis and Autophagy Regulation: Therapeutic Implications
por: Ferreira, Anabela, et al.
Publicado: (2022)

IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER
por: ZANATTO, Renato Morato, et al.
Publicado: (2020)

Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery
por: Chen, Wei, et al.
Publicado: (2021)

The role of [Formula: see text] F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2020)

The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients
por: Ye, Shuang, et al.
Publicado: (2022)

Targeting KRAS G12C mutations in colorectal cancer
por: Zhao, Ming-He, et al.
Publicado: (2022)

Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome
por: Lemstrova, Radmila, et al.
Publicado: (2017)

Histology and its prognostic effect on KRAS-mutated colorectal carcinomas in Korea
por: Lee, Hye Seung, et al.
Publicado: (2020)

Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations
por: Pal, Rekha, et al.
Publicado: (2018)

Clinical features and KRAS mutation in colorectal cancer with bone metastasis
por: Park, Hyung Soon, et al.
Publicado: (2020)

Clinical characteristics of patients with KRAS mutation detected by liquid biopsy
por: Amino, Yoshiaki, et al.
Publicado: (2023)

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
por: Zhang, Zining, et al.
Publicado: (2023)

KRAS mutations and endometriosis burden of disease
por: Orr, Natasha L, et al.
Publicado: (2023)

KRAS mutations are negatively correlated with immunity in colon cancer
por: Fu, Xiaorui, et al.
Publicado: (2020)

Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation
por: Zeng, Da-xiong, et al.
Publicado: (2017)

Clinical-Pathological Correlation of KRAS Mutation Status in Metastatic Colorectal Adenocarcinoma
por: Ribeiro, Karen Bento, et al.
Publicado: (2013)

KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research
por: He, Kang, et al.
Publicado: (2020)

Assessment of Resistance Mechanisms and Clinical Implications in Patients with KRAS Mutated-Metastatic Breast Cancer and Resistance to CDK4/6 Inhibitors
por: Raimondi, Lucrezia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bsnmfmk5bfuc9n48oopltnl99a